News3/Ratings1
Latest news
3 items- NEWSAstraZeneca Says Lynparza/Imfinzi Combo Shows Strong Clinical Benefit Vs. Chemotherapy In Endometrial CancerMonday, AstraZeneca Plc (NASDAQ:PLC) released latest analysis of the results from the DUO-E Phase 3 trial of Imfinzi (durvalumab) plus platinum-based chemotherapy followed by Imfinzi plus Lynparza (olaparib) (Lynparza and Imfinzi arm) in mismatch repair proficient (pMMR) advanced or recurrent endometrial cancer compared to chemotherapy alone. The data demonstrated an improvement in multiple key secondary efficacy endpoints, particularly in patients with mismatch repair proficient (pMMR) advanced or recurrent endometrial cancer compared to chemotherapy alone. A post-hoc exploratory subgroup analysis assessed patients by mismatch repair (MMR) status, a biomarker of interest in endometria
- ANALYSTRBC Capital reiterated coverage on Park Lawn with a new price targetRBC Capital reiterated coverage of Park Lawn with a rating of Outperform and set a new price target of $50.00 from $46.00 previously
- ANALYSTRBC Capital reiterated coverage on Park Lawn with a new price targetRBC Capital reiterated coverage of Park Lawn with a rating of Outperform and set a new price target of $43.00 from $39.00 previously
PLC FAQ
7 questionsWhat does Principal U.S. Large-Cap Multi-Factor Core Index ETF do?
The investment seeks to provide investment results that closely correspond, before expenses, to the performance of the Nasdaq US Large Cap Select Leaders Core Index. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of U.S. companies with large market capitalizations that compose the index at the time of purchase. The index uses a quantitative model designed to identify equity securities of companies in the Nasdaq US Large Cap Index that exhibit potential for high degrees of value, quality growth and...Where does PLC stock trade?
Principal U.S. Large-Cap Multi-Factor Core Index ETF (PLC) is listed on NASDAQ.What sector and industry is PLC in?
Principal U.S. Large-Cap Multi-Factor Core Index ETF operates in the n/a sector.When did Principal U.S. Large-Cap Multi-Factor Core Index ETF go public?
Principal U.S. Large-Cap Multi-Factor Core Index ETF (PLC) completed its IPO in n/a.What are analysts saying about PLC?
Principal U.S. Large-Cap Multi-Factor Core Index ETF has had 1 recent analyst action on file. The most recent action was from RBC Capital: Outperform on 2021-09-14.What companies are similar to PLC?
Notable peers in the same industry include CBOE (Cboe Global Markets, Inc.), HCXY (Hercules Capital, Inc.), PCI (PIMCO Dynamic Credit and Mortgage Income Fund), BXS (BancorpSouth Bank), AJAX (Ajax I). Compare PLC side-by-side with any of them on Quantisnow.How can I track PLC on Quantisnow?
Quantisnow aggregates Principal U.S. Large-Cap Multi-Factor Core Index ETF's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PLC to receive live email and push alerts on every new disclosure.